StockWatch
·

PHARMAIDS PHARMACEUTICALS LTD. Q4 FY26 Results

PHARMAIDQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue7.1832.3%50.7%
Total Income7.2832.3%50.4%
Expenditure8.655.2%16.1%
PBT-1.4663.8%73.0%
Net Profit-1.0859.0%77.4%
OPM-5.96%47.51pp74.75pp
NPM-14.90%33.16pp84.30pp
EPS0.5127.1%54.0%
View full financials

Informational and educational content only. Not investment advice.